FeNO
The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.
A PCRS Consensus: FeNO testing for asthma diagnosis
The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.
Guide to FeNO Testing
In this article produced for Practice Nurse, author, PCRS Chair, Carol Stonham, describes FeNO testing and its role in diagnosing respiratory disease. She discusses the advantages and limitations of this test.
FeNO for the diagnosis and management of asthma
Resources from the Academic Health Science Network (AHSN) Programme
Wessex AHSN have developed a number of resources to support you to develop your FeNO project using QI methodology.
accuRx has created a FeNO template to send to patients prior to their appointment via text message. For information on what's included and how to find the template, have a look at the guidance document below.
As with any test or procedure it is really important that your patient has a full understanding of what to expect from their FeNO test appointment, along with an explanation of the test process.
Understanding how language can play a big barrier in healthcare delivery
Ardens, providers of TPP SystmOne and EMIS Web templates and resources, have created templates to support the use of FeNO testing.
Resources from the Academic Health Science Network (AHSN) Programme
In this article produced for Practice Nurse, author, PCRS Chair, Carol Stonham, describes FeNO testing and its role in diagnosing respiratory disease. She discusses the advantages and limitations of this test.
On the 6 February, NHS England issued an update to the GP contract agreement 2020/21 to 2023–23/24. The update includes important improvements to the asthma and COPD domains.